Maze Therapeutics, Inc. Common Stock (MAZE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for MAZE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 155 institutions reported holding MAZE, with 58.5 million shares worth $1.7 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Frazier Life Sciences Management | 5,032,915 | $150M | INCREASED |
| Trv GP IV | 4,473,958 | $134M | UNCHANGED |
| Arch Venture Management | 4,120,053 | $123M | UNCHANGED |
| Deep Track Capital | 3,732,569 | $111M | INCREASED |
| BlackRock | 3,502,841 | $105M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Maze Therapeutics, Inc. Common Stock on SentiSense.